Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

PHASE3CompletedINTERVENTIONAL
Enrollment

503

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

May 31, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

linagliptin

active

DRUG

placebo

placebo

Trial Locations (69)

Unknown

1218.16.38605 Boehringer Ingelheim Investigational Site, Krapinske Toplice

1218.16.38604 Boehringer Ingelheim Investigational Site, Slavonski Brod

1218.16.91009 Boehringer Ingelheim Investigational Site, Andhra Pradesh

1218.16.91002 Boehringer Ingelheim Investigational Site, Bangalore

1218.16.91005 Boehringer Ingelheim Investigational Site, Bangalore

1218.16.91014 Boehringer Ingelheim Investigational Site, Chennai

1218.16.91013 Boehringer Ingelheim Investigational Site, Ghaziabad

1218.16.91010 Boehringer Ingelheim Investigational Site, Hyderabad

1218.16.91006 Boehringer Ingelheim Investigational Site, Jaipur

1218.16.91011 Boehringer Ingelheim Investigational Site, Maharashtra

1218.16.91008 Boehringer Ingelheim Investigational Site, Mangalore

1218.16.91007 Boehringer Ingelheim Investigational Site, Manipal

1218.16.91004 Boehringer Ingelheim Investigational Site, Mumbai

1218.16.91003 Boehringer Ingelheim Investigational Site, Nashik

1218.16.91012 Boehringer Ingelheim Investigational Site, Tamilnadu

1218.16.91001 Boehringer Ingelheim Investigational Site, Trivandrum, Kerala

1218.16.97267 Boehringer Ingelheim Investigational Site, Giv‘atayim

1218.16.97263 Boehringer Ingelheim Investigational Site, Haifa

1218.16.97265 Boehringer Ingelheim Investigational Site, Holon

1218.16.97261 Boehringer Ingelheim Investigational Site, Jerusalem

1218.16.97262 Boehringer Ingelheim Investigational Site, Nahariya

1218.16.97266 Boehringer Ingelheim Investigational Site, Safed

1218.16.39004 Boehringer Ingelheim Investigational Site, Catanzaro

1218.16.39008 Boehringer Ingelheim Investigational Site, Genova

1218.16.39002 Boehringer Ingelheim Investigational Site, Milan

1218.16.39001 Boehringer Ingelheim Investigational Site, Pisa

1218.16.39006 Boehringer Ingelheim Investigational Site, Roma

1218.16.60006 Boehringer Ingelheim Investigational Site, Alor Star

1218.16.60003 Boehringer Ingelheim Investigational Site, Kelantan Kota Bahru

1218.16.60001 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1218.16.60002 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1218.16.60004 Boehringer Ingelheim Investigational Site, Perak

1218.16.60005 Boehringer Ingelheim Investigational Site, Perak

1218.16.60007 Boehringer Ingelheim Investigational Site, Pulau Pinang

1218.16.31009 Boehringer Ingelheim Investigational Site, Andijk

1218.16.31024 Boehringer Ingelheim Investigational Site, Castricum

1218.16.31006 Boehringer Ingelheim Investigational Site, Deurne

1218.16.31001 Boehringer Ingelheim Investigational Site, Ewijk

1218.16.31010 Boehringer Ingelheim Investigational Site, Losser

1218.16.31003 Boehringer Ingelheim Investigational Site, Oude Pekela

1218.16.31021 Boehringer Ingelheim Investigational Site, Poortvliet

1218.16.31004 Boehringer Ingelheim Investigational Site, Rijswijk

1218.16.31008 Boehringer Ingelheim Investigational Site, Roelofarendsveen

1218.16.31002 Boehringer Ingelheim Investigational Site, Wildervank

1218.16.48603 Boehringer Ingelheim Investigational Site, Lublin

1218.16.48601 Boehringer Ingelheim Investigational Site, Warsaw

1218.16.48604 Boehringer Ingelheim Investigational Site, Zabrze

1218.16.40604 Boehringer Ingelheim Investigational Site, Brasov

1218.16.40603 Boehringer Ingelheim Investigational Site, Galati

1218.16.42103 Boehringer Ingelheim Investigational Site, Banská Bystrica

1218.16.42102 Boehringer Ingelheim Investigational Site, Bratislava

1218.16.42104 Boehringer Ingelheim Investigational Site, Bratislava

1218.16.42105 Boehringer Ingelheim Investigational Site, Bratislava

1218.16.42101 Boehringer Ingelheim Investigational Site, Nové Mesto nad Váhom

1218.16.42106 Boehringer Ingelheim Investigational Site, Šamorín

1218.16.66001 Boehringer Ingelheim Investigational Site, Bangkok

1218.16.66002 Boehringer Ingelheim Investigational Site, Khon Kaen

1218.16.38011 Boehringer Ingelheim Investigational Site, Dnipro

1218.16.38002 Boehringer Ingelheim Investigational Site, Kharkiv

1218.16.38004 Boehringer Ingelheim Investigational Site, Kharkiv

1218.16.38010 Boehringer Ingelheim Investigational Site, Kharkiv

1218.16.38001 Boehringer Ingelheim Investigational Site, Kiev

1218.16.38005 Boehringer Ingelheim Investigational Site, Kiev

1218.16.38008 Boehringer Ingelheim Investigational Site, Kiev

1218.16.38009 Boehringer Ingelheim Investigational Site, Kiev

1218.16.38012 Boehringer Ingelheim Investigational Site, Kiev

1218.16.38003 Boehringer Ingelheim Investigational Site, Lviv

1218.16.38006 Boehringer Ingelheim Investigational Site, Vinnitsa

1218.16.38007 Boehringer Ingelheim Investigational Site, Zaporizhzhya

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY